(S)-(+)-Glycidyl Phthalimide Cas 161596-47-0

Product Overview: (S)-(+)-Glycidyl Phthalimide (CAS 161596-47-0)

Table of Contents

• 1. Technical Specifications & Comparative Analysis
• 2. Key Applications
• 3. Industrial Use Cases
• 4. Verified Client Implementations
• 5. Inquiry & Custom Solutions

1. Technical Specifications & Comparative Analysis

2. Key Applications

This chiral intermediate is critical for:

• Synthesis of Rivaroxaban API for VTE prevention
• Asymmetric catalysis in anticoagulant production
• Pharmaceutical intermediate for thrombin inhibitors

3. Industrial Use Cases

Case 1: Anticoagulant Manufacturing

Used as key intermediate in batch processes requiring ≥99.5% enantiomeric excess for FDA-compliant API synthesis.

Case 2: Research-Scale Applications

Enables precise pharmacokinetic studies due to consistent purity profiles across multiple synthesis routes.

4. Verified Client Implementations

Client A: European Pharma Manufacturer

Annual consumption: 850kg for rivaroxaban production with 12-month stability data validation.

Client B: US Research Consortium

Validated 97% yield improvement in scaled-up synthesis through optimized process parameters.

5. Inquiry & Custom Solutions

Contact our technical team for:

• Batch-specific COA requests
• GMP-grade production capabilities
• Custom synthesis protocols

Email: info@vivalr.com
Phone: (86) 15866781826